489 related articles for article (PubMed ID: 12912815)
1. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P
Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815
[TBL] [Abstract][Full Text] [Related]
2. Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene.
Staritz P; Kurz K; Stoll M; Giannitsis E; Katus HA; Ivandic BT
Int J Cardiol; 2009 Apr; 133(3):341-5. PubMed ID: 18485500
[TBL] [Abstract][Full Text] [Related]
3. Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome.
Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Lambert M; Camoin L; Vague IJ; Bonnet JL; Alessi MC
Thromb Res; 2007; 120(6):893-9. PubMed ID: 17337040
[TBL] [Abstract][Full Text] [Related]
4. [Genetic variants of platelet ADP receptor P2Y12 associated with changed platelet functional activity and development of cardiovascular diseases].
Sirotkina OV; Zabotina AM; Berkovich OA; Bazhenova EA; Vavilova TV; Shvartsman AL
Genetika; 2009 Feb; 45(2):247-53. PubMed ID: 19334620
[TBL] [Abstract][Full Text] [Related]
5. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
Pampuch A; Cerletti C; de Gaetano G
Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
[TBL] [Abstract][Full Text] [Related]
6. P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study.
Fontana P; Gaussem P; Aiach M; Fiessinger JN; Emmerich J; Reny JL
Circulation; 2003 Dec; 108(24):2971-3. PubMed ID: 14662702
[TBL] [Abstract][Full Text] [Related]
7. Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP.
Hetherington SL; Singh RK; Lodwick D; Thompson JR; Goodall AH; Samani NJ
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):252-7. PubMed ID: 15514209
[TBL] [Abstract][Full Text] [Related]
8. Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease.
Cavallari U; Trabetti E; Malerba G; Biscuola M; Girelli D; Olivieri O; Martinelli N; Angiolillo DJ; Corrocher R; Pignatti PF
BMC Med Genet; 2007 Sep; 8():59. PubMed ID: 17803810
[TBL] [Abstract][Full Text] [Related]
9. P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose.
von Beckerath N; von Beckerath O; Koch W; Eichinger M; Schömig A; Kastrati A
Blood Coagul Fibrinolysis; 2005 Apr; 16(3):199-204. PubMed ID: 15795539
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
Storey RF; May JA; Heptinstall S
Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C
Thromb Res; 2005; 116(6):491-7. PubMed ID: 16181985
[TBL] [Abstract][Full Text] [Related]
12. Common variation in the platelet receptor P2RY12 gene is associated with residual on-clopidogrel platelet reactivity in patients undergoing elective percutaneous coronary interventions.
Rudez G; Bouman HJ; van Werkum JW; Leebeek FW; Kruit A; Ruven HJ; ten Berg JM; de Maat MP; Hackeng CM
Circ Cardiovasc Genet; 2009 Oct; 2(5):515-21. PubMed ID: 20031628
[TBL] [Abstract][Full Text] [Related]
13. Effect of P2Y1 and P2Y12 genetic polymorphisms on the ADP-induced platelet aggregation in a Korean population.
Kim KA; Song WG; Lee HM; Joo HJ; Park JY
Thromb Res; 2013 Aug; 132(2):221-6. PubMed ID: 23849096
[TBL] [Abstract][Full Text] [Related]
14. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel.
Lev EI; Patel RT; Guthikonda S; Lopez D; Bray PF; Kleiman NS
Thromb Res; 2007; 119(3):355-60. PubMed ID: 16581111
[TBL] [Abstract][Full Text] [Related]
16. Platelet inhibition by insulin is absent in type 2 diabetes mellitus.
Ferreira IA; Mocking AI; Feijge MA; Gorter G; van Haeften TW; Heemskerk JW; Akkerman JW
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):417-22. PubMed ID: 16339499
[TBL] [Abstract][Full Text] [Related]
17. The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor.
Bouman HJ; van Werkum JW; Rudez G; Leebeek FW; Kruit A; Hackeng CM; Ten Berg JM; de Maat MP; Ruven HJ
Thromb Haemost; 2010 Feb; 103(2):379-86. PubMed ID: 20126830
[TBL] [Abstract][Full Text] [Related]
18. Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3.
Storey RF; Melissa Thornton S; Lawrance R; Husted S; Wickens M; Emanuelsson H; Cannon CP; Heptinstall S; Armstrong M
Platelets; 2009 Aug; 20(5):341-8. PubMed ID: 19637098
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
[TBL] [Abstract][Full Text] [Related]
20. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
